1 – 27 of 27
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation
2024) In Cardiovascular Research(
- Contribution to journal › Article
- 2023
-
Mark
Therapeutic S100A8/A9 blockade inhibits myocardial and systemic inflammation and mitigates sepsis-induced myocardial dysfunction
(
- Contribution to journal › Article
- 2021
-
Mark
Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
IL-2Rβγ signalling in lymphocytes promotes systemic inflammation and reduces plasma cholesterol in atherosclerotic mice
(
- Contribution to journal › Article
- 2019
-
Mark
Elevated circulating effector memory T cells but similar levels of regulatory T cells in patients with type 2 diabetes mellitus and cardiovascular disease
(
- Contribution to journal › Article
-
Mark
Lack of Ability to Present Antigens on Major Histocompatibility Complex Class II Molecules Aggravates Atherosclerosis in ApoE-/- Mice
(
- Contribution to journal › Article
-
Mark
ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions
(
- Contribution to journal › Article
- 2018
-
Mark
Interleukin-25 reduces Th17 cells and inflammatory responses in human peripheral blood mononuclear cells
(
- Contribution to journal › Article
-
Mark
B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice
(
- Contribution to journal › Article
-
Mark
Interleukin-25 (IL-25) has a protective role in atherosclerosis development in the aortic arch in mice
(
- Contribution to journal › Article
- 2016
-
Mark
CD4(+) CD56(+) natural killer T-like cells secreting interferon-γ are associated with incident coronary events.
(
- Contribution to journal › Article
- 2015
-
Mark
IL-25 Inhibits Atherosclerosis Development in Apolipoprotein E Deficient Mice.
(
- Contribution to journal › Article
-
Mark
IL-22 affects smooth muscle cell phenotype and plaque formation in apolipoprotein E knockout mice.
(
- Contribution to journal › Article
- 2014
-
Mark
Circulating CD40+ and CD86+ B Cell Subsets Demonstrate Opposing Associations With Risk of Stroke.
(
- Contribution to journal › Article
- 2013
-
Mark
Association between CD8(+) T cell subsets and cardiovascular disease.
(
- Contribution to journal › Article
-
Mark
T-Helper 2 Immunity Is Associated With Reduced Risk of Myocardial Infarction and Stroke.
2013) In Arteriosclerosis, Thrombosis and Vascular Biology(
- Contribution to journal › Article
- 2012
-
Mark
TAP1-Deficiency Does Not Alter Atherosclerosis Development in Apoe(-/-) Mice.
(
- Contribution to journal › Article
-
Mark
Elevated CD14++CD16- Monocytes Predict Cardiovascular Events.
(
- Contribution to journal › Article
-
Mark
Low Levels of Circulating CD4+FoxP3+ T Cells Are Associated With an Increased Risk for Development of Myocardial Infarction But Not for Stroke.
(
- Contribution to journal › Article
- 2011
-
Mark
Immunization with cationized BSA inhibits progression of disease in ApoBec-1/LDL receptor deficient mice with manifest atherosclerosis.
(
- Contribution to journal › Article
-
Mark
Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine.
(
- Contribution to journal › Article
- 2008
-
Mark
Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodies.
(
- Contribution to journal › Article
- 2007
-
Mark
Inhibition of injury-induced arterial remodelling and carotid atherosclerosis by recombinant human antibodies against aldehyde-modified apoB-100.
(
- Contribution to journal › Article
-
Mark
Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(-/-)/low-density lipoprotein receptor(-/-) mice.
(
- Contribution to journal › Article
-
Mark
Autoimmune responses against the apo B-100 LDL receptor-binding site protect against arterial accumulation of lipids in LDL receptor deficient mice.
(
- Contribution to journal › Article
- 2002
-
Mark
Interleukin-1 receptor antagonist is detectable in human carotid artery plaques and is related to triglyceride levels and Chlamydia pneumoniae IgA antibodies.
(
- Contribution to journal › Article
-
Mark
The presence of elafin, SLPI, IL1-RA and STNFalpha RI in head and neck squamous cell carcinomas and their relation to the degree of tumour differentiation.
(
- Contribution to journal › Article